ESPOSITO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 4.066
EU - Europa 1.297
AS - Asia 577
AF - Africa 221
SA - Sud America 34
OC - Oceania 8
Totale 6.203
Nazione #
US - Stati Uniti d'America 4.033
IT - Italia 720
IN - India 218
SG - Singapore 193
CN - Cina 146
TG - Togo 107
FI - Finlandia 106
NG - Nigeria 105
UA - Ucraina 103
SE - Svezia 80
BG - Bulgaria 53
DE - Germania 49
AT - Austria 47
FR - Francia 44
GB - Regno Unito 33
CA - Canada 31
AR - Argentina 28
IE - Irlanda 17
BE - Belgio 12
AU - Australia 7
ES - Italia 7
RO - Romania 7
TR - Turchia 7
NL - Olanda 5
BR - Brasile 4
CH - Svizzera 4
ZA - Sudafrica 4
EG - Egitto 3
GR - Grecia 3
JP - Giappone 3
CL - Cile 2
GT - Guatemala 2
HR - Croazia 2
IL - Israele 2
IQ - Iraq 2
KR - Corea 2
MY - Malesia 2
RU - Federazione Russa 2
SC - Seychelles 2
HU - Ungheria 1
IR - Iran 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PL - Polonia 1
Totale 6.203
Città #
Fairfield 674
Woodbridge 346
Chandler 344
Ashburn 329
Houston 294
Rome 286
Seattle 241
Wilmington 206
Cambridge 205
Ann Arbor 174
Singapore 169
Princeton 120
San Paolo di Civitate 114
Lomé 107
Plano 90
Dearborn 75
Lawrence 73
Boston 69
Beijing 56
Sofia 53
Millbury 46
San Diego 42
Vienna 41
Grafing 38
Jacksonville 34
Federal 28
Helsinki 27
Andover 24
Toronto 24
Norwalk 20
Boardman 19
Dublin 17
Nanjing 14
Kunming 13
Los Angeles 13
Des Moines 10
Milan 10
Salerno 10
Teramo 10
Brussels 9
Fiano Romano 8
Nanterre 8
San Mateo 8
Anguillara 7
Falls Church 7
Lavello 7
Legnano 7
Melbourne 7
Istanbul 6
Laurel 6
Napoli 6
Dobbs Ferry 5
Hefei 5
Nanchang 5
Naples 5
New York 5
Phoenix 5
Bologna 4
Indiana 4
London 4
Modena 4
Newton Upper Falls 4
Padova 4
Pune 4
Shanghai 4
Vedelago 4
Viterbo 4
Wuhan 4
Buffalo 3
Cumignano sul Naviglio 3
Fuzhou 3
Guangzhou 3
Hebei 3
Hoogstraten 3
Hyderabad 3
Jinan 3
Maddaloni 3
Montreal 3
Pomezia 3
Raleigh 3
Rieti 3
Shenyang 3
Tarragona 3
Verona 3
Washington 3
Woolwich 3
Amsterdam 2
Assisi 2
Baghdad 2
Barcelona 2
Belluno 2
Bethesda 2
Bühl 2
Cagliari 2
Cava de' Tirreni 2
Centrale 2
Chengdu 2
Chieti 2
Chongqing 2
Delhi 2
Totale 4.707
Nome #
Next-Generation Probiotics for Inflammatory Bowel Disease 186
Autologous transplantation of intestine-isolated glia cells improves neuropathology and restores cognitive deficits in β amyloid-induced neurodegeneration 119
inPentasomes: an innovative nose-to-brain pentamidine delivery blunts MPTP parkinsonism in mice 105
Allele-specific transcriptional activity of the variable number of tandem repeats of the inducible nitric oxide synthase gene is associated with idiopathic achalasia 96
Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement 95
Palmitoylethanolamide modulates inflammation-associated vascular endothelial growth factor (VEGF) signaling via the Akt/mTOR pathway in a selective peroxisome proliferator-activated receptor alpha (PPAR-α)-dependent manner. 92
Lathyrus sativus diamine oxidase counteracts histamine-induced cell proliferation, migration and pro-angiogenic mediators release in human colon adenocarcinoma cell line caco-2 90
Analysis of calretinin early expression in the rat hippocampus after beta amyloid (1-42) peptide injection 83
Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells 82
Lathyrus sativus diamine oxidase reduces clostridium difficile toxin a-induced toxicity in caco-2 cells by rescuing rhoa-gtpase and inhibiting pp38-mapKknf-κb/hif-1α activation 82
Cannabidiol in Medicine: A Review of its Therapeutic Potential in CNS Disorders 80
Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway 80
Enteric glia: a new player in inflammatory bowel diseases 80
Rifaximin improves clostridium difficile toxin A-induced toxicity in caco-2 cells by the PXR-dependent TLR4/MyD88/NF-κB pathway 80
S100B inhibitor pentamidine attenuates reactive gliosis and reduces neuronal loss in a mouse model of Alzheimer's disease 78
Palmitoylethanolamide regulates production of pro-angiogenic mediators in a model of β amyloid-induced astrogliosis in vitro. 78
Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide 78
HIV-1 Tat-induced diarrhea is improved by the PPAR alpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia 77
Opposing control of cannabinoid receptor stimulation on amyloid-{beta} induced reactive gliosis: in vitro and in vivo evidence. 77
HIV-1 Tat-induced diarrhea evokes an enteric glia-dependent neuroinflammatory response in the central nervous system 73
Enteric Glial-Derived S100B Protein Stimulates Nitric Oxide Production in Celiac Disease 73
Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes 72
Ultramicronized Palmitoylethanolamide Inhibits NLRP3 Inflammasome Expression and Pro-Inflammatory Response Activated by SARS-CoV-2 Spike Protein in Cultured Murine Alveolar Macrophages 72
Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells 71
Palmitoylethanolamide Exerts Antiproliferative Effect and Downregulates VEGF Signaling in Caco-2 Human Colon Carcinoma Cell Line Through a Selective PPAR-α-Dependent Inhibition of Akt/mTOR Pathway 71
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α 70
Selective CB2 up-regulation in women affected by endometrial inflammation 70
Aplidiasterols A and B, two new cytotoxic 9,11-secosterols from the mediterranean ascidian Aplidium conicum 69
Endocannabinoid-related compounds in gastrointestinal diseases 69
ADELMIDROL, A PALMITOYLETHANOLAMIDE ANALOG, REDUCES CHRONIC INFLAMMATION IN A CARRAGEENIN-GRANULOMA ODEL IN RATS 68
S100B and APP promote a gliocentric shift and impaired neurogenesis in down syndrome neural progenitors 68
Cannabinoids reduce granuloma-associated angiogenesis in rats by controlling transcription and expression of mast cell protease-5. 68
Play in advance against neurodegeneration: exploring enteric glial cells in gut-brain axis during neurodegenerative diseases 68
A palmitoylethanolamide producing lactobacillus paracasei improves clostridium difficile toxin a-induced colitis 67
Local administration of WIN 55,212-2 reduces chronic granuloma-associated angiogenesis in rat by inhibiting NF-kappaB activation. 66
S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells. 65
S100B-p53 disengagement by pentamidine promotes apoptosis and inhibits cellular migration via aquaporin-4 and metalloproteinase-2 inhibition in C6 glioma cells 65
Are Anti-Angiogenic Drugs Useful in Neurodegenerative Disorders? 65
Melatonin reverses lipopolysaccharide-induced gastro-intestinal motility disturbances through the inhibition of oxidative stress. 64
Global hypermethylation in fetal cortex of Down syndrome due to DNMT3L overexpression 64
The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-beta peptide-induced neurotoxicity 64
Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation 64
Pentamidine niosomes thwart S100B effects in human colon carcinoma biopsies favouring wtp53 rescue 64
Induction of nitric oxide synthase expression by Withania somnifera in macrophages 62
Oxalomalate affects the inducible nitric oxide synthase expression and activity 62
Engineered Lactobacillus paracasei Producing Palmitoylethanolamide (PEA) Prevents Colitis in Mice 62
Dietary methods using lactobacillus paracasei subsp. paracasei f19 as nape-pld gene carrier for producing on demand pea or oea and relative biological dietary compositions thereof 61
Cannabidiol: A Promising Drug for Neurodegenerative Disorders ? 60
Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein. 60
Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression. 60
The antiprotozoal drug pentamidine ameliorates experimentally induced acute colitis in mice 60
CB1 receptor selective activation inhibits β-amyloid-induced Inos protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons 59
Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis 59
Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement 58
Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation 57
Cannabidiol inhibits SARS-Cov-2 spike (S) protein-induced cytotoxicity and inflammation through a PPARγ-dependent TLR4/NLRP3/Caspase-1 signaling suppression in Caco-2 cell line 57
Phytotherapics in COVID19: why palmitoylethanolamide? 56
S100B protein in the gut: The evidence for enteroglial-sustained intestinal inflammation 55
Differential Cannabinoid Receptor Expression during Reactive Gliosis: a Possible Implication for a Nonpsychotropic Neuroprotection 55
Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPARγ involvement 54
Selective cannabinoid CB1 receptor-mediated inhibition of inducible nitric oxide synthase protein expression in C6 rat glioma cells. 53
Novel bioactive sulfated alkene and alkanes from the Mediterranean ascidian Halocynthia papillosa 53
Cannabinoid CB(1) receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro. 53
OLIG2 over-expression impairs proliferation of human Down syndrome neural progenitors 53
The endocannabinoid system protects rat glioma cells against HIV-1 Tat protein-induced cytotoxicity. Mechanism and regulation. 52
Role of Enteric Glia as Bridging Element between Gut Inflammation and Visceral Pain Consolidation during Acute Colitis in Rats 50
Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB(1) receptors and fatty acid amide hydrolase 49
The potential of cannabidiol in the COVID-19 pandemic. 47
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview 46
Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion? 46
Impaired duodenal palmitoylethanolamide release underlies acid-induced mast cell activation in functional dyspepsia 46
Cannabidiol in vivo suppresses Aβ-induced reactive gliosis. 45
High-fat diet impairs duodenal barrier function and elicits glia-dependent changes along the gut-brain axis that are required for anxiogenic and depressive-like behaviors 45
Minor steroidal alkaloids from the marine sponge Corticium sp. 44
Acetonic extract from the feijoa sellowiana berg. fruit exerts antioxidant properties and modulates disaccharidases activities in human intestinal epithelial cells 43
N-Palmitoyl-D-Glucosamine Inhibits TLR-4/NLRP3 and Improves DNBS-Induced Colon Inflammation through a PPAR-α-Dependent Mechanism 42
Turbinamide, a new selective cytotoxic agent from the Mediterranean tunicate Sidnyum turbinatum. 42
S100B protein promoted tau protein hyperphosphorilation through DKK-1 protein up-regulation and relative Wnt pathway disruption in cultured human neurons. 40
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. 40
Cannabidiol inhibits beta amyloid-induced reactive gliosis through peroxisome proliferator-activated receptor-gamma involvement. 38
The astroglial-derived S100beta protein stimulates the expression of nitric oxide synthase in rodent macrophages through p38 MAP kinase activation 37
Young Researcher Award 2019 - Dipartimento di Fisiologia e Farmacologia "V. Erspamer", Università Sapienza di Roma 37
Nutraceuticals and Diet Supplements in Crohn’s Disease: A General Overview of the Most Promising Approaches in the Clinic 37
Endocannabinoids in the treatment of gasytrointestinal inflammation and symptoms 36
S100B protein stimulates proliferation and angiogenic mediators release through RAGE/pAkt/mTOR pathway in human colon adenocarcinoma Caco-2 Cells 36
BIOLOGICAL COMPOSITION BASED ON ENGINEERED LACTOBACILLUS PARACASEI SUBSP. PARACASEI F19 FOR THE BIOSYNTHESIS OF CANNABINOIDS 36
Possibile ruolo delle ALIAmidi nelle patologie degenerative del sistema nervoso. 35
Genomic and functional profiling of human Down syndrome neural progenitor implicates S100B and Aquaporin 4 in cell injury 35
Oral Adelmidrol Administration Up-Regulates Palmitoylethanolamide Production in Mice Colon and Duodenum through a PPAR-γ Independent Action 33
Antinflammatory/neuroprotective properties of palmitoylethanolamide in a model of Alzheimer’s disease 32
Palmitoylethanolamide counteracts reactive gliosis in an in vivo model of Alzheimer’s disease 31
Anti-inflammatory/neuroprotective properties of palmitoylethanolamide in a model of beta amyloid neurotoxicity. 31
Cannabidiol inhibits beta amyloid-induced reactive gliosis through peroxisome proliferator-activated receptor-gamma involvement. 31
Palmitoylethanolamide counteracts reactive astrogliosis in in vitro models of Alzheimer’s disease 30
Cannabidiol controls intestinal inflammation through the modulation of enteric glial cell activation. 29
PPARγ mediates cannabidiol antiinflammatory and neuroprotective effects in an in vitro model of Alzheimer’s disease. 29
The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells. 29
Cannabinoids and PPARs: new tools for Alzheimer’s disease treatment. 28
Palmitoylethanolamide counteracts reactive astrogliosis in in vitro models of Alzheimer’s disease 28
Palmitoylethanolamide is able to attenuate astrocyte activation and neuroinflammation in models of Alzheimer’s desease 28
Totale 5.940
Categoria #
all - tutte 15.919
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 195
selected - selezionate 0
volume - volumi 0
Totale 16.114


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019462 0 0 0 0 0 0 0 0 0 0 243 219
2019/20201.308 190 39 8 55 122 191 195 151 132 76 47 102
2020/2021594 68 77 40 40 18 50 9 48 85 74 57 28
2021/20221.389 18 66 118 37 156 147 28 130 102 101 273 213
2022/20231.324 234 336 61 119 154 123 25 65 105 20 61 21
2023/2024740 36 90 26 53 201 106 26 64 16 118 4 0
Totale 6.439